Literature DB >> 6377948

Inhibition of human aldehyde dehydrogenase isozymes by propiolaldehyde.

K Ferencz-Biro, R Pietruszko.   

Abstract

Propiolaldehyde--a metabolite of pargyline (Shirota et al., 1979) can function as an inhibitor or as a substrate of human aldehyde dehydrogenase (EC 1.2.1.3), dependent on conditions. In the presence of high concentration of NAD, propiolaldehyde is a substrate for both the cytoplasmic E1 isozyme and the mitochondrial E2 isozyme. The Km values are comparable to those with other short chain aldehydes; the maximal velocity is also similar for E2 but lower by about three-fold for E1. Preincubation with propiolaldehyde in the absence of NAD produces inactivation with K1 values of 1.6 microM for E1 and 1.8 microM for E2. NAD, but not propanal, protects both isozymes against inactivation with propiolaldehyde.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6377948     DOI: 10.1111/j.1530-0277.1984.tb05516.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  2 in total

Review 1.  Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.

Authors:  Vindhya Koppaka; David C Thompson; Ying Chen; Manuel Ellermann; Kyriacos C Nicolaou; Risto O Juvonen; Dennis Petersen; Richard A Deitrich; Thomas D Hurley; Vasilis Vasiliou
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

2.  Critical role of mitochondrial aldehyde dehydrogenase 2 in acrolein sequestering in rat spinal cord injury.

Authors:  Seth A Herr; Liangqin Shi; Thomas Gianaris; Yucheng Jiao; Siyuan Sun; Nick Race; Scott Shapiro; Riyi Shi
Journal:  Neural Regen Res       Date:  2022-07       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.